| Abbreviations | Meaning |
 | BCA | Breast Cancer Antigen |
| MSV | Murine Sarcoma Virus |
| MOMLV, MO-MLV | Moloney Murine Leukemia Virus |
| TNFAR | Tumor Necrosis Factor Alpha Receptor |
| PT | Pertussis Toxin; Postoperative Tumor Size [TNM (tumor-node-metastasis) Classification: PT0 Surgery Not Done Or Not Applicable, PT1 No Visible Tumor Tissue, PT2 Less Than 1.5 Cm Remains, PT3 1.5 To 5.0 Cm Remains, PT4 More Than 5.0 Cm Remains To Primary Tumors In Progressing Thickness, And PTX No Evidence Of Primary Tumor] |
| NCIC CTG | National Cancer Institute Of Canada Clinical Trial Group |
| AGC-FN | Atypical Glandular Cell-favor Neoplasia |
| LCIS | Lobular Carcinoma In Situ |
| TAL | Tumor-associated Lymphocyte |
| ALV | Abelson Leukemia Virus |
| PLCC | Primary Liver Cell Cancer |
| NOD | Naito-Oyanagi Disease; National Organization On Disability; Nodular Melanoma; Nonobese Diabetic [mouse]; Notify Of Death |
| PERNET | Peripheral Neuroectodermal Tumor |
| UR2SV | UR2 Sarcoma Virus |
| MUMTV | Murine Mammary Tumor Virus |
Browse by Letter:
